|
|
|
|
LEADER |
04737nam a22004575i 4500 |
001 |
978-0-387-28274-9 |
003 |
DE-He213 |
005 |
20150520190648.0 |
007 |
cr nn 008mamaa |
008 |
100301s2005 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387282749
|9 978-0-387-28274-9
|
024 |
7 |
|
|a 10.1007/0-387-28274-2
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RC254-282
|
072 |
|
7 |
|a MJCL
|2 bicssc
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.994
|2 23
|
245 |
1 |
0 |
|a Malignant Mesothelioma
|h [electronic resource] :
|b Advances in Pathogenesis, Diagnosis, and Translational Therapies /
|c edited by Harvey I. Pass, Nicholas J. Vogelzang, Michele Carbone.
|
264 |
|
1 |
|a New York, NY :
|b Springer New York,
|c 2005.
|
300 |
|
|
|a XXVI, 854 p. 178 illus.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Carcinogenesis -- The History of Mesothelioma -- Asbestos-Induced Mesothelioma -- SV40-Mediated Oncogenesis -- Mesothelioma Carcinogenesis: In Vivo Models -- Mesothelial and Mesothelioma Cell Lines -- Molecular Genetics -- Cytogenetics of Malignant Mesothelioma -- Growth Factors and Malignant Mesothelioma -- Oncogenes and Tumor Suppressor Genes in Malignant Mesothelioma -- Angiogenesis and Mesothelioma -- Immune Status and Mesothelioma -- Extracellular Matrix and Mesothelioma: Some Clues to the Invasive Behavior of Mesothelioma -- Genomics and Proteomics in Mesothelioma -- Epidemiology -- Asbestos Mineralogy and Health Effects -- Molecular Epidemiology of Mesothelioma -- Malignant Mesothelioma and Erionite -- Determination of Asbestos Exposure by Pathology and Clinical History -- Mesothelioma and Asbestos Exposure -- From Monkey to Man: The Epidemiologic Evidence of an Association Between Simian Virus 40 and Malignancy -- Causes and Prevention of Technical Artifacts When Studying Simian Virus 40 (SV40) in Human Mesotheliomas -- Molecular Detection of Siman Virus 40 in Human Mesothelioma -- Malignant Mesothelioma Following Radiation -- Genetics and Human Mesothelioma -- Clinical Presentation -- Clinicians’ Approach to Mesothelioma -- Clinical Presentation and Natural History of Mesothelioma: Pleural and Pericardial -- Clinical Presentation and Natural History of Mesothelioma: Abdominal -- Staging of Mesothelioma -- Prognostic Factors in Mesothelioma -- Imaging and Endoscopy -- Radiologic Assessment of Mesothelioma -- Endoscopic Imaging -- Pathology -- Benign Mesotheliomas, Mesothelial Proliferations, and Their Possible Association with Asbestos Exposure -- Cytology of Malignant Mesothelioma -- Immunohistochemistry -- Malignant Mesothelioma Electron Microscopy -- Rare Variants of Mesothelioma -- Differentiating Sarcomas from Mesotheliomas -- Diagnosis of Synovial Sarcoma of the Pleura and Differentiation from Malignant Mesothelioma -- Pitfalls in the Diagnosis of Malignant Mesothelioma -- Treatment -- Management of Benign Variants of Mesothelioma -- First-Line Chemotherapy for Malignant Pleural Mesothelioma -- Second-Line Chemotherapy -- Treatment of Mesothelioma with Radiotherapy -- Multimodality Approaches -- Intrapleural Chemotherapy with and Without Surgery in Malignant Pleural Mesothelioma (MPM) -- Management of Pleural Effusions in Mesothelioma -- Preoperative Chemotherapy and Surgery -- Photodynamic Therapy for Pleural Mesothelioma -- Surgery and Postoperative Radiotherapy -- The Development of the Brigham and Women’s Multimodality Treatment Plan for Malignant Pleural Mesothelioma: A Model for Improving the Treatment of Rare Diseases -- Peritoneal Mesothelioma: The Columbia Experience -- Surgery, Hyperthermic Chemoperfusion, and Postoperative Chemotherapy: The National Cancer Institute and Washington Hospital Center Experience -- Pericardial and Tunica Vaginalis Mesothelioma -- Novel Treatment Strategies -- New Target Therapies for Malignant Mesothelioma -- Gene Therapy for Malignant Pleural Mesothelioma -- Immunotherapeutic Approaches and Vaccination Strategies -- Economic Implications -- Economic Aspects of Mesothelioma.
|
520 |
|
|
|a no bcc - textbook design.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Oncology.
|
650 |
|
0 |
|a Thoracic surgery.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Thoracic Surgery.
|
700 |
1 |
|
|a Pass, Harvey I.
|e editor.
|
700 |
1 |
|
|a Vogelzang, Nicholas J.
|e editor.
|
700 |
1 |
|
|a Carbone, Michele.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387229492
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/0-387-28274-2
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|